STAT+: The White House declares ‘promises made, promises kept’ on lowering drug prices. Nice try
In its effort to lower drug prices, the White House has declared "promises made, promises kept." That's a narrative that doesn't reflect the full story.
President Trump is poised to appoint Heidi Overton, the White House's deputy director for domestic policy, as the next commissioner of the Food and Drug Administration, a source familiar with the situation disclosed. Overton, a prominent voice in health policy during Trump's second term, has occasionally clashed with leaders of the Make America Healthy Again movement.
Should Trump opt for her, Overton would need to undergo scrutiny by a Senate panel prior to assuming her role. Overton has been a fixture at the White House since the beginning of Trump's tenure and has been instrumental in shaping health policy, including initiatives to revamp the food pyramid, reassess the childhood vaccine schedule, and negotiate pricing agreements with pharmaceutical firms. Further details await at STAT+.
Written by urgent.news from STAT News's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
